What is a Poison Pill? Definition, Formula, and Example
A poison pill is a shareholder rights plan that lets existing shareholders buy discounted shares once an acquirer crosses a set ownership threshold, diluting the acquirer and making a hostile takeover prohibitively expensive.
Poison Pill: Plain-English Definition
A poison pill — formally a "shareholder rights plan" — is a defensive measure a company's board adopts to deter a hostile takeover. The mechanism is simple in concept: if any single shareholder acquires stock above a pre-set threshold (commonly 10-20%) without board approval, every other shareholder gains the right to buy new shares at a steep discount to market price. That mass discounted issuance dilutes the acquirer's stake and multiplies the cost of the takeover, effectively forcing the acquirer to either negotiate directly with the board or walk away. The board can adopt a poison pill unilaterally, without a shareholder vote, which is why it's controversial — it's a management entrenchment tool as much as a shareholder protection tool, and courts (particularly Delaware's Court of Chancery) have spent decades litigating where that line falls.
How It's Structured
A standard rights plan works as follows:
1. The board declares a dividend of one "right" per outstanding share, with no immediate value.
2. Rights become exercisable only when a triggering event occurs — typically an entity acquiring beneficial ownership above the threshold (a "flip-in" pill) without board consent.
3. Once triggered, every shareholder except the acquirer can buy new shares at a discount — commonly 50% of market value — using their rights.
4. The resulting share issuance dilutes the acquirer's percentage stake, often cutting its effective ownership and voting power dramatically, and makes completing the takeover far more expensive.
Some plans also include a "flip-over" provision: if the hostile acquirer completes a merger anyway, target shareholders get the right to buy the acquirer's stock at a discount instead. Most modern pills include sunset clauses (commonly 1 year) requiring the board to either let them lapse or seek shareholder ratification.
Worked Example: Twitter vs. Elon Musk (2022)
On April 15, 2022, Twitter's board adopted a poison pill after Elon Musk disclosed a 9% stake and made an unsolicited $43 billion buyout offer. The plan triggered at 15% ownership — well below the traditional 20% norm, reflecting how seriously the board viewed the threat. Under the plan, if any person or group crossed 15% without board approval, all other shareholders would gain the right to buy additional shares at a 50% discount to market price, diluting the acquirer's position. The pill was set to expire in April 2023. It never actually triggered — Musk instead negotiated directly with the board and signed a merger agreement at $54.20/share in late April 2022, and after a public dispute over bot-account disclosures, the deal ultimately closed in October 2022. The pill did its job: it forced a negotiated deal rather than an open-market creep to control.
When Companies and Traders Use It
Boards adopt poison pills reactively, within days of an activist or hostile bidder crossing a disclosure threshold (5% under Schedule 13D rules), specifically to buy time to evaluate the offer, solicit competing bids, or negotiate a higher price. Merger-arbitrage traders watch pill adoptions closely — a newly adopted pill signals the board is fighting the current offer price, which often precedes a bidding war or a sweetened bid rather than deal collapse. Activist investors price pill risk into their accumulation strategy, often stopping deliberately just below the trigger threshold (9% in Musk's case, versus a 15% trigger) to avoid tripping it while building a stake and pressuring the board publicly instead.
Limitations and Common Misconceptions
A poison pill does not permanently block a takeover — it buys time and negotiating leverage, not a veto. Delaware courts require pills to be a proportionate response to a legitimate threat (the *Unocal* standard), and boards that adopt overly aggressive pills to entrench themselves against a fairly priced, non-coercive offer risk having the pill struck down in litigation. Pills also don't stop proxy fights — an acquirer blocked from buying more stock can still wage a campaign to replace the board directly at the next annual meeting, which is a separate mechanism a pill doesn't defend against. Finally, a pill's mere existence in a company's charter (a "shelf" pill, adopted preemptively with no active threat) is common as standing insurance and doesn't signal an active takeover fight — only a pill adopted in direct response to a specific accumulating stake does.